Items where authors include "Harrison, L."

Article

Flatley, S. orcid.org/0000-0002-5484-4781, Dixon, S., Pilsworth, E. et al. (4 more authors) (2025) Diabetes mellitus in patients with autoimmune hepatitis: frequency, risk factors and effect on outcome. Alimentary Pharmacology & Therapeutics, 62 (3). pp. 319-329. ISSN 0269-2813

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Shivakumar, V., Neill, G., McKenzie, S. et al. (3 more authors) (2025) Observational cohort study of patients with chronic liver disease undergoing variceal screening and surveillance using capsule endoscopy. Frontline Gastroenterology. flgastro-2024. ISSN 2041-4137

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Beanland, R. orcid.org/0000-0003-1749-4134, Harrison, L. orcid.org/0009-0007-2200-3500, Khan, S. orcid.org/0009-0004-4823-3679 et al. (5 more authors) (2023) Temperature dependence of incommensurate modulation in Ca0.28Ba0.72Nb2O6. Journal of Applied Physics, 134 (6). 064101. ISSN 0021-8979

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Proctor, V.K. orcid.org/0000-0001-6720-6773, O’Connor, O.M., Burns, F.A. et al. (114 more authors) (2023) Surgical site infections after emergency hernia repair: substudy from the Management of Acutely Symptomatic Hernia (MASH) study. BJS Open, 7 (1). zrac155. ISSN 2474-9842

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Jones, L., Boeri, M., Christie, M. et al. (14 more authors) (2022) Can we model cultural ecosystem services, and are we measuring the right things? People and Nature, 4 (1). pp. 168-179. ISSN 2575-8314

Neve, P., Barney, J.N., Buckley, Y. et al. (32 more authors) (2018) Reviewing research priorities in weed ecology, evolution and management: a horizon scan. Weed Research, 58 (4). pp. 250-258. ISSN 0043-1737

Harrison, L., Kumar, S., Bull, M. et al. (3 more authors) (2017) Clinical case series describes a contraindication for SerenoCem Granules™ in mastoid obliteration: Our experience in sixty-four patients. Clinical Otolaryngology, 42 (5). pp. 1095-1100. ISSN 1749-4478

McRae, J.F., Clayton, S., Fitzgerald, T.W. et al. (299 more authors) (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542 (7642). pp. 433-438. ISSN 0028-0836

Fitzgerald, T.W., Gerety, S.S., Jones, W.D. et al. (263 more authors) (2015) Large-scale discovery of novel genetic causes of developmental disorders. Nature, 519. pp. 223-228. ISSN 0028-0836

Wyness, M., Harrison, L. and Buchanan, I. (2004) Childhood, Politics and Ambiguity: Towards an Agenda for Children's Political Inclusion. Sociology - Sage Journals, 38 (1). pp. 81-99. ISSN 0038-0385